abstract |
[Object] To provide a sustained-release preparation for suppressing angiogenesis. A composition for inhibiting angiogenesis, comprising a sustained-release preparation containing NK4 DNA and a biodegradable polymer hydrogel, and a sustained-release preparation containing NK4 DNA and a biodegradable polymer hydrogel. The composition of the present invention is used as a cancer therapeutic agent for suppressing cancer invasion and metastasis, and for ophthalmic diseases such as age-related macular degeneration, diabetic retinopathy and retinopathy of prematurity, hemangiomas, rheumatoid arthritis, and psoriasis. It is useful as a therapeutic and prophylactic agent for diseases associated with angiogenesis, such as edema sclerosis. [Selection diagram] None |